
### [Orphanet:275736](http://www.orpha.net/ORDO/Orphanet_275736)
**Label:** Rare hemorrhagic disorder due to a qualitative platelet defect

**Subclasses:** [Orphanet:420566](http://www.orpha.net/ORDO/Orphanet_420566) (Bleeding disorder due to CalDAG-GEFI deficiency), [Orphanet:806](http://www.orpha.net/ORDO/Orphanet_806) (Scott syndrome), [Orphanet:73271](http://www.orpha.net/ORDO/Orphanet_73271) (Bleeding diathesis due to a collagen receptor defect), [Orphanet:849](http://www.orpha.net/ORDO/Orphanet_849) (Glanzmann thrombasthenia), [Orphanet:52530](http://www.orpha.net/ORDO/Orphanet_52530) (Pseudo-von Willebrand disease), [Orphanet:36355](http://www.orpha.net/ORDO/Orphanet_36355) (P2Y12 defect), [Orphanet:75501](http://www.orpha.net/ORDO/Orphanet_75501) (Ehlers-Danlos syndrome, fibronectinemic type), 

**Corr. equiv. classes:** [Orphanet:52530](http://www.orpha.net/ORDO/Orphanet_52530), [Orphanet:73271](http://www.orpha.net/ORDO/Orphanet_73271), [OMIM:273800](http://purl.obolibrary.org/obo/OMIM_273800), [OMIM:609821](http://purl.obolibrary.org/obo/OMIM_609821), [OMIM:225310](http://purl.obolibrary.org/obo/OMIM_225310), [OMIM:262890](http://purl.obolibrary.org/obo/OMIM_262890), [OMIM:177820](http://purl.obolibrary.org/obo/OMIM_177820), [OMIM:614201](http://purl.obolibrary.org/obo/OMIM_614201), [OMIM:614200](http://purl.obolibrary.org/obo/OMIM_614200), [Orphanet:849](http://www.orpha.net/ORDO/Orphanet_849), [OMIM:615888](http://purl.obolibrary.org/obo/OMIM_615888), [Orphanet:806](http://www.orpha.net/ORDO/Orphanet_806), [Orphanet:420566](http://www.orpha.net/ORDO/Orphanet_420566), [Orphanet:36355](http://www.orpha.net/ORDO/Orphanet_36355), [Orphanet:75501](http://www.orpha.net/ORDO/Orphanet_75501), 

**Class expressions from DL-Learner:**

- [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) and (not ([HP:0011842](http://purl.obolibrary.org/obo/HP_0011842) (Abnormality of skeletal morphology))) 38.33%
- [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) and (not ([HP:0001367](http://purl.obolibrary.org/obo/HP_0001367) (Abnormal joint morphology))) 33.75%
- [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) 31.01%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 30.93%
- [HP:0001892](http://purl.obolibrary.org/obo/HP_0001892) (Abnormal bleeding) 30.79%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 28.31%
- Thing 28.30%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 28.30%
- [HP:0000978](http://purl.obolibrary.org/obo/HP_0000978) (Bruising susceptibility) 23.54%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) 21.83%
- [HP:0001933](http://purl.obolibrary.org/obo/HP_0001933) (Subcutaneous hemorrhage) 21.75%
- [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) 19.67%
- [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 19.26%
- [HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin) 19.14%
- [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) 18.84%


